Humanigen Inc (HGENQ)

[bobshmob]

HGEN has a good shot at $20+/share this year. Hang in there.

HGEN may (or may not) have a better shot at covid-19 than CYDY does, but covid is very much an after thought for CYDY. HIV (which uses CCR5 for entering the cell but is blocked by leronlimab) is #1, with metastatic triple-negative breast cancer looking promising. Other big indications are possible too because surprisingly often CCR5 is overexpressed, causing more problems than it solves.